Resources

Recombinant Insulin insights

As the leading supplier of Recombinant Insulin for innovative biologics, Novo Nordisk Pharmatech helps you keep development on track, production flowing, and products timely supplied to hospitals and patients.

Recombinant Insulin is used to manufacture monoclonal antibodies, virus vaccines, gene therapy products, and other biological drug products approved by regulatory bodies worldwide, including the FDA and EMA.

Find below our collection of case studies and educational material about Recombinant Insulin (Insulin Human AF) and explore how it has been used to improve cell culture and boost protein production.

We provide excellence at every step of the supply chain, beginning with the quality of our insulin, directly sourced from Novo Nordisk A/S, the largest producer of insulin in the world. With 100+ years of experience with Insulin, Novo Nordisk ensures the most stable and well-established manufacturing processes and specialist know-how on the market.

In case of any further questions, please contact us.

Case studies

Enhancing hiPSC culture quality with Recombinant Insulin supplementation
Pluripotent stem cells
Optimizing CHO-K1 fed-batch cell culture medium for mAb production
Monoclonal antibodies
Optimizing CHO-S cell culture medium by supplementation with animal-free insulin
Monoclonal antibodies
Exploring the effects of insulin on viral vectors production in HEK293 cells
Viral vectors for gene therapy
Improving Influenza virus production in HEK293 cell culture supplemented with animal-free insulin
Cell-based vaccinees
Supplementation of Recombinant Insulin to insect SF9 cell culture to improve cell growth and baculovirus-driven VLP production
Cell-based vaccinees
Optimization of HEK 293 cell growth by addition of non-animal derived components using design of experiments
Cell-based vaccineesMonoclonal antibodiesViral vectors for gene therapy

Infographics

Recombinant Insulin infographic
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy

Webinars

Enhancing process efficiency with high-quality animal-free ingredients
Case study – Boost the production of monoclonal antibodies in CHO cells
Case study- Increase the viral vector production in HEK293 cells
Recombinant Insulin is the essential cell culture ingredient to boost cell proliferation and productivity
Accelerate the scale-up to clinical phase
Effect of Insulin on influence production in HEK293 Cells
Cell-based vaccinees

Insulin learnings

The Insulin peptide family
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy
The insulin and IGF-1 receptors
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy
How insulin and IGF-1 bind to their receptors
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy
Insulin and IGF-1 receptor signalling pathways: Where is the specificity?
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy
A short history of cell culture media and the use of insulin
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy
How cells grow, the discovery of Insulin like growth factors
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy
Regulation of apoptosis by insulin and IGF-1
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy
Regulation of the cell cycle by insulin and IGF1
Cell-based vaccineesMonoclonal antibodiesPluripotent stem cellsViral vectors for gene therapy

Insulin e-book

More about Recombinant Insulin